Markets:

Overview

News

Currencies

International

Treasuries

MaxCyte, Inc. - Common Stock (NQ:MXCT)

0.7104 -0.0296 (-4.00%)

Streaming Delayed Price Updated: 10:45 AM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about MaxCyte, Inc. - Common Stock

< Previous 1 2 3 4 Next >

MaxCyte (MXCT) Q4 2025 Earnings Call Transcript ↗

March 24, 2026

MaxCyte (MXCT) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

MaxCyte Inc (NASDAQ:MXCT) Reports Q4 2025 Revenue Miss and Cautious 2026 Outlook ↗

March 24, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Insights into MaxCyte's Upcoming Earnings ↗

November 11, 2025

Via Benzinga

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗

August 11, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

A Look at MaxCyte's Upcoming Earnings Report ↗

May 06, 2025

Via Benzinga

Thursday's session: top gainers and losers ↗

August 07, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 07, 2025

Via Benzinga

Which stocks are moving on Thursday? ↗

August 07, 2025

Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Traders are paying attention to the gapping stocks in Thursday's session. ↗

August 07, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

MaxCyte (MXCT) Q2 Revenue Drops 18% ↗

August 06, 2025

Via The Motley Fool

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 12, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

March 11, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Earnings Scheduled For March 11, 2025 ↗

March 11, 2025

Via Benzinga

MarketBeat Week in Review – 01/20 - 01/24

January 25, 2025

Stocks surged higher as investors reacted positively to dovish tariff news; next week will be highlighted by the Federal Reserve meeting and some tech earnings

Via MarketBeat

Topics Economy Government World Trade

MaxCyte: Building the Future of Cell and Gene Therapy Innovation

January 23, 2025

MaxCyte's proprietary Flow Electroporation technology enables companies like Vertex and CRISPR Therapeutics to get FDA approved for their gene-editing therapy.

Via MarketBeat

MXCT Stock Earnings: MaxCyte Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

MXCT stock results show that MaxCyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 08, 2024

Via Benzinga

Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday ↗

May 08, 2024

Via Benzinga

MXCT Stock Earnings: MaxCyte Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

MXCT stock results show that MaxCyte beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket ↗

March 20, 2024

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.

Via Benzinga

Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 20, 2024

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

Via Benzinga

Topics Stocks

NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

March 13, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

March 13, 2024

U.S. stock futures were mixed this morning, with the Nasdaq futures falling by around 20 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 12, 2024

Via Benzinga

Earnings Scheduled For March 12, 2024 ↗

March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.